Motter Fabiane Raquel, Fritzen Janaína Soder, Hilmer Sarah Nicole, Paniz Érika Vieira, Paniz Vera Maria Vieira
Postgraduate Program in Collective Health, University of Vale do Rio dos Sinos (UNISINOS), Av. Unisinos, 920, Sao Leopoldo, RS, 93022-000, Brazil.
Department of Clinical Pharmacology and Aged Care, Kolling Institute, Royal North Shore Hospital and University of Sydney, Reserve Road, St Leonards, NSW, 2065, Australia.
Eur J Clin Pharmacol. 2018 Jun;74(6):679-700. doi: 10.1007/s00228-018-2446-0. Epub 2018 Mar 27.
Potentially inappropriate medication (PIM) use causes preventable adverse drug reactions in older patients. Several assessment tools have been published to identify and avoid PIM use. In this systematic literature review, we aim to provide summaries and comparisons of validated PIMs lists published between 1991 and 2017 internationally.
In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement (PRISMA), we performed a systematic review of articles describing the development and validation of criteria for identification of PIMs among older people published between January 1991 and April 2017. The searches were conducted on PUBMED, AgeLine, Academic Search, Academic Search Premier, and CINAHL. We identified the most common medications/classes described as PIM. We also identified the drug-disease interactions and drug-drug interactions reported among criteria.
From 2933 articles screened, 36 met our inclusion criteria. The majority used the Delphi method to validate their criteria. We identified 907 different medications/classes, 536 different drug disease interactions involving 84 diseases/conditions, and 159 drug-drug interactions. Benzodiazepines and nonsteroidal anti-inflammatory drugs were the medications most commonly reported as potentially inappropriate for older people.
Although approaches aimed at detecting inappropriate prescribing have intensified in recent years, we observed limited overlap between different PIM lists. Additionally, some PIM lists did not provide special considerations of use and alternative therapies to avoid PIMs. These facts may compromise the use of PIM lists in clinical practice. Future PIM lists should integrate information about alternative therapies and special considerations of use in order to help clinicians in the drug prescription.
潜在不适当用药(PIM)会在老年患者中引发可预防的药物不良反应。已发布了多种评估工具来识别并避免PIM的使用。在这项系统文献综述中,我们旨在对1991年至2017年间在国际上发布的经过验证的PIM清单进行总结和比较。
根据系统评价和Meta分析的首选报告项目声明(PRISMA),我们对1991年1月至2017年4月期间发表的描述老年人中PIM识别标准的制定和验证的文章进行了系统综述。检索在PubMed、AgeLine、学术搜索、学术搜索高级版和CINAHL上进行。我们确定了被描述为PIM的最常见药物/类别。我们还确定了标准中报告的药物-疾病相互作用和药物-药物相互作用。
在筛选的2933篇文章中,36篇符合我们的纳入标准。大多数使用德尔菲法来验证其标准。我们确定了907种不同的药物/类别、涉及84种疾病/病症的536种不同的药物-疾病相互作用以及159种药物-药物相互作用。苯二氮卓类药物和非甾体抗炎药是最常被报告为对老年人可能不适当的药物。
尽管近年来旨在检测不适当处方的方法有所加强,但我们观察到不同的PIM清单之间的重叠有限。此外,一些PIM清单没有提供使用方面的特殊考虑以及避免PIM的替代疗法。这些事实可能会影响PIM清单在临床实践中的使用。未来的PIM清单应整合有关替代疗法和使用方面特殊考虑的信息,以帮助临床医生进行药物处方。